Inmunotek S.L.

Address: Calle Punto Mobi 5

Sponsor Overview

assignment

Specializations

Allergic Rhinitis and Rhinoconjunctivitis

Clinical research focuses on moderate-to-severe intermittent and persistent allergic rhinitis and rhinoconjunctivitis, including cases associated with controlled mild-to-moderate allergic asthma. The portfolio includes both seasonal and perennial disease patterns.

Grass pollen and cupressaceae allergy
Birch pollen-induced respiratory allergy
House dust mite-associated disease

Research activity also covers symptom control during pollen seasons and the clinical burden linked to allergen exposure in adolescents and adults.

Allergen Immunotherapy

The sponsor funds studies in specific immunotherapy for respiratory allergy, with interest in subcutaneous immunotherapy and sublingual immunotherapy approaches. The work centers on allergen-directed treatment for patients sensitized to inhalant allergens.

Polymerized allergen extracts
Mannan-conjugated allergoids
Dust mite and mixed pollen immunotherapy

Key therapeutic areas include treatment of sensitization to Dermatophagoides pteronyssinus, Dermatophagoides farinae, and related aeroallergens.

Aeroallergen Characterisation

Part of the research portfolio is devoted to the assessment of allergenic extracts and their biological activity, with a focus on defining potency for clinically relevant airborne allergens.

Blomia tropicalis
Lepidoglyphus destructor
Phleum pratense and Dactylis glomerata

Additional interest extends to Quercus ilex, Quercus robur, and birch pollen, reflecting a broad focus on environmental allergens relevant to respiratory disease.

Recurrent Urinary Tract Infections

The sponsor also supports clinical research in recurrent non-complicated urinary tract infections, with attention to prevention of repeated infectious episodes in women with localized recurrent cystitis.

Mucosal bacterial immunotherapy
Recurrent cystitis
Infection recurrence reduction

This area broadens the therapeutic scope beyond allergy into urogenital infectious disease.

Sponsored Trials

Trial Name	Country	Status
A Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous Mannan-Conjugated Betula Pendula Pollen Allergoid in Birch Pollen-Induced Allergic Rhinitis	Germany Poland	Not Recruiting
Assessment of Blomia tropicalis Allergen Extract Concentration in Skin Prick Test for Patients with Blomia tropicalis Allergy Using Histamine Dihydrochloride Control	Spain	Not Recruiting
Diagnostic accuracy of Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen extracts for skin prick testing in patients with house dust mite allergy	Spain	Not Yet Recruiting
Efficacy and safety of MG01 and T517 drug combination in patients with allergic rhinitis or rhinoconjunctivitis, with or without mild‑moderate asthma	Spain	Not Recruiting
Efficacy and Safety of Subcutaneous Dermatophagoides Allergoid Immunotherapy in Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma	Spain	Not Recruiting
Efficacy of a polymerized mannan‑conjugated Phleum pratense and Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis/rhinoconjunctivitis	Germany	Not Recruiting
Evaluation of a Sublingual Vaccine's Induction of Trained Immunity in Peripheral Blood Cells of Healthy Adult Males and Non-Pregnant Females	Spain	Recruiting
Evaluation of Allergenic Potency of Lepidoglyphus Destructor Extract in Patients with Allergy Using Histamine Equivalent Prick Testing Units	Spain	Not Recruiting
Evaluation of Efficacy and Safety of Subcutaneous Immunotherapy with Modified Allergen Extracts in Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma	Spain	Recruiting
Evaluation of Efficacy and Safety of Sublingual MM09 in Patients with Allergic Rhinitis/Rhinoconjunctivitis and Mild to Moderate Asthma Due to Dermatophagoides spp.	Portugal Spain	Recruiting